Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)
ACS Med Chem Lett
.
2021 Oct 20;12(11):1641-1642.
doi: 10.1021/acsmedchemlett.1c00532.
eCollection 2021 Nov 11.
Author
Ram W Sabnis
1
Affiliation
1
Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID:
34795852
PMCID:
PMC8591715
DOI:
10.1021/acsmedchemlett.1c00532
No abstract available
Publication types
Editorial